HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition
Top Cited Papers
Open Access
- 15 March 2009
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (6) , 2743-2755
- https://doi.org/10.1128/jvi.02265-08
Abstract
Human immunodeficiency virus type 1 (HIV-1) elite controllers (EC) maintain viremia below the limit of commercial assay detection (240-249 TW10 epitope. The typical escape mutation (T242N) within this epitope diminishes viral replication capacity in chronically infected persons; however, little is known about TW10 epitope sequences in residual replicating viruses in B57/B*5801 EC and the extent to which mutations within this epitope may influence steady-state viremia. Here we analyzed TW10 in a total of 50 B57/B*5801-positive subjects (23 EC and 27 viremic subjects). Autologous plasma viral sequences from both EC and viremic subjects frequently harbored the typical cytotoxic T-lymphocyte (CTL)-selected mutation T242N (15/23 sequences [65.2%] versus 23/27 sequences [85.1%], respectively; P = 0.18). However, other unique mutants were identified in HIV controllers, both within and flanking TW10, that were associated with an even greater reduction in viral replication capacity in vitro. In addition, strong CTL responses to many of these unique TW10 variants were detected by gamma interferon-specific enzyme-linked immunospot assay. These data suggest a dual mechanism for durable control of HIV replication, consisting of viral fitness loss resulting from CTL escape mutations together with strong CD8 T-cell immune responses to the arising variant epitopes.Keywords
This publication has 38 references indexed in Scilit:
- Continuous Viral Escape and Selection by Autologous Neutralizing Antibodies in Drug-Naïve Human Immunodeficiency Virus ControllersJournal of Virology, 2009
- HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1Journal of Virology, 2009
- Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 InfectionJournal of Virology, 2008
- Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 InfectionThe Journal of Experimental Medicine, 2004
- HIV evolution: CTL escape mutation and reversion after transmissionNature Medicine, 2004
- The Differential Ability of HLA B*5701+Long-Term Nonprogressors and Progressors To Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous ViralgagSequencesJournal of Virology, 2003
- Magnitude of Functional CD8+T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in PlasmaJournal of Virology, 2002
- Frequency and function of HIV-specific CD8+ T CellsImmunology Letters, 2001
- Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV InfectionThe Journal of Experimental Medicine, 2001
- HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressorsProceedings of the National Academy of Sciences, 2000